You have 9 free searches left this month | for more free features.

[C-11]NOP-1A, [C-11]NPA , nociceptive opioid peptide receptors, dopamine release

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

Completed
  • Alcohol Use Disorder
  • Pittsburgh, Pennsylvania
    University of PIttsburgh PET Facility
Jul 8, 2022

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
    New Haven, Connecticut
Jan 18, 2023

Alcohol Use Disorder Trial in Toronto ([11C]-(+)-PHNO PET scan, Alcohol Self-Administration, Craving Task)

Completed
  • Alcohol Use Disorder
  • [11C]-(+)-PHNO PET scan
  • +4 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 27, 2020

Healthy Volunteers Trial in London (Amphetamine, TAK -041, [11C] (+)-4-propyl-(+)-4-propyl-9-hydroxynaphthoxazine (PHNO))

Completed
  • Healthy Volunteers
  • London, United Kingdom
    Hammersmith Medicines Research
Mar 17, 2021

Cocaine Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

Completed
  • Cocaine Use Disorder
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Aug 2, 2019

Pain, Anxiety, Depression Trial run by the NIMH (NOP-1A)

Completed
  • Pain
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Healthy Trial in Pittsburgh (Hydrocortisone, [C-11]NOP-1A)

Completed
  • Healthy
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Oct 2, 2020

Functional Relevance of Dopamine Receptors in Healthy Controls

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

    Not yet recruiting
    • Alcohol Use Disorder
    • Detoxification Program
    • +2 more
    • (no location specified)
    Jul 13, 2023

    Pain Trial in Houston (anakinra, Placebo, Nociceptive pain challenge)

    Recruiting
    • Pain
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jan 19, 2022

    Opioid Use, Enhanced Recovery After Surgery, Anesthesia Trial in Nashville (Ketamine, Placebo)

    Enrolling by invitation
    • Opioid Use
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 31, 2023

    Cocaine-Related Disorders Trial in Pittsburgh (d-amphetamine, [C-11]NPA)

    Completed
    • Cocaine-Related Disorders
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Sep 2, 2020

    MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Major Depressive Disorder
    • Toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Sep 7, 2023

    MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

    Recruiting
    • Major Depressive Disorder
    • Toludivenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Jun 14, 2023

    Hip Arthropathy, Hip Disease Trial in Montauban (Dexmedetomidine, Sufentanil)

    Recruiting
    • Hip Arthropathy
    • Hip Disease
    • Montauban, Tarn Et Garonne, France
      Edmundo Pereira de Souza Neto
    Jul 6, 2022

    Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence Trial (Naltrexone-Bupropion Combination)

    Not yet recruiting
    • Obesity, Morbid
    • +2 more
    • Naltrexone-Bupropion Combination
    • (no location specified)
    Jul 26, 2022

    Stress Response Trial (tDCS actif, tDCS Sham)

    Not yet recruiting
    • Stress Response
    • tDCS actif
    • tDCS Sham
    • (no location specified)
    Apr 20, 2023

    Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

    Not yet recruiting
    • Gilles de la Tourette Syndrome
    • Tourette Syndrome
    • PET/MR scanner
    • Leipzig, Germany
      Max Planck Institute for Human Cognitive and Brain Sciences
    Feb 11, 2022

    Substance Abuse, Suicide, Depression Trial in Houston (Repetitive Transcranial Magnetic Stimulation (rTMS), sham rTMS)

    Recruiting
    • Substance Abuse
    • +2 more
    • Repetitive Transcranial Magnetic Stimulation (rTMS)
    • sham rTMS
    • Houston, Texas
      The Menninger Clinic
    Aug 3, 2022

    Trigeminal Neuropathy, Traumatic Trial in Paris (BOTOX®, Allergan, Placebo)

    Active, not recruiting
    • Trigeminal Neuropathy, Traumatic
    • BOTOX®, Allergan
    • Placebo
    • Paris, France
      Groupe Hospitalier Pitié-Salpêtrière
    Jun 27, 2022

    Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Multiple Dose Insulin Therapy
    • Personalized treatment
    • (no location specified)
    Nov 18, 2023

    MDD Trial in Tübingen (Ghrelin, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Tübingen, BW, Germany
      Department of Psychiatry & Psychotherapy, University of Tübingen
    Apr 7, 2022

    Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release

    Not yet recruiting
    • Moderate to Severe Opioid Use Disorder
    • Extended Release Subcutaneous Buprenorphine
    • Immediate Release Sublingual Buprenorphine
    • Barrie, Ontario, Canada
    • +4 more
    Oct 20, 2022

    Pain, Chronic, Opioid Dependence, Opioid Use Trial in New York (Root.Health Dietary Supplement)

    Enrolling by invitation
    • Pain, Chronic
    • +3 more
    • Root.Health Dietary Supplement
    • New York, New York
      Hudson Medical
    Jun 9, 2023